Prevalence and Risk Factors of Pediatric Delirium in Critically Ill Children: A Study Using Cornell Assessment of

Muhammad Nashit1, Anwar Ul Haque2, Sadiq Mirza3

  • 1Department of Clinical Affairs, ChildLife Foundation, Karachi, Sindh, Pakistan.

Insights

Pediatric delirium affects nearly a quarter of critically ill children. Key risk factors include comorbidities, developmental delay, and certain medications, highlighting the need for early detection using the Cornell Assessment of Pediatric Delirium.

Area of Science:

  • Pediatric Critical Care Medicine
  • Neuroscience
  • Clinical Assessment Tools

Background:

  • Delirium is a common complication in critically ill children.
  • Early detection and management are crucial for improving outcomes.
  • The Cornell Assessment of Pediatric Delirium (CAPD)-revised is a validated tool for this purpose.

Purpose of the Study:

  • To determine the prevalence of delirium in critically ill children.
  • To identify associated risk factors for pediatric delirium.
  • To evaluate the utility of the CAPD-revised tool in a real-world setting.

Main Methods:

  • A descriptive cross-sectional study was conducted with 201 critically ill children (1 month-14 years).
  • Delirium was assessed twice daily for three days using the CAPD-revised tool.
  • A score of ≥9 on the CAPD-revised was considered diagnostic for delirium.

Main Results:

  • Delirium was identified in 24.9% of the pediatric intensive care unit patients.
  • Significant risk factors included comorbidities (OR=3.45), developmental delay (OR=5.12), benzodiazepine use (OR=2.89), antiepileptic use (OR=2.67), high-flow oxygen (OR=2.31), and mechanical ventilation (OR=3.12).
  • The mean age of affected children was 5.14 years, with 61.7% being male.

Conclusions:

  • Nearly one-quarter of critically ill children experienced delirium.
  • Comorbidities, developmental delay, sedative use, and advanced respiratory support were key risk factors.
  • The CAPD-revised tool is valuable for routine screening and early management of pediatric delirium.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
743
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
250
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
241
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
458